Results 161 to 170 of about 120,035 (227)
Substance use and menopausal symptoms among people with and without HIV in the US, 2008-2020. [PDF]
MenopauseKnittel AK, Knittel AK, Bullington BW, Edmonds A, Rahangdale L, Neal-Perry G, Ramirez C, Konkle-Parker D, Jones DL, Moran CA, Topper EF, Cejtin H, Seidman D, Kasseye SG, Wilson TE, Sharma A, Adimora AA. +16 moreeuropepmc +1 more sourceDynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. [PDF]
Lancet Microbe, 2023 Zhu X, Gebo KA, Abraham AG, Habtehyimer F, Patel EU, Laeyendecker O, Gniadek TJ, Fernandez RE, Baker OR, Ram M, Cachay ER, Currier JS, Fukuta Y, Gerber JM, Heath SL, Meisenberg B, Huaman MA, Levine AC, Shenoy A, Anjan S, Blair JE, Cruser D, Forthal DN, Hammitt LL, Kassaye S, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Abinante M, Broderick P, Cluzet V, Cordisco ME, Greenblatt B, Petrini J, Rausch W, Shade D, Lane K, Gawad AL, Klein SL, Pekosz A, Shoham S, Casadevall A, Bloch EM, Hanley D, Sullivan DJ, Tobian AAR. +47 moreeuropepmc +1 more sourceUtility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. [PDF]
Hepatol CommunSanyal AJ, Loomba R, Anstee QM, Ratziu V, Kowdley KV, Rinella ME, Harrison SA, Resnick MB, Capozza T, Sawhney S, Shelat N, Younossi ZM. +11 moreeuropepmc +1 more sourceExacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population. [PDF]
Respir MedQuezada WA, Angulo D, Murray S, Joo M, Han M, Make B, Thomashow B, Mannino D, Tapp H, Martinez F, Yawn BP. +10 moreeuropepmc +1 more sourceThe Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLD. [PDF]
JHEP RepTiniakos DG, Bedossa P, Arola J, Davies S, Gouw ASH, Guido M, Lackner C, Schirmacher P, Terracciano L, Blain A, Wonders K, Anstee QM, Ratziu V, Paradis V. +13 moreeuropepmc +1 more sourceExpert consensus on the management of systemic sclerosis-associated interstitial lung disease. [PDF]
Respir Res, 2023 Rahaghi FF, Hsu VM, Kaner RJ, Mayes MD, Rosas IO, Saggar R, Steen VD, Strek ME, Bernstein EJ, Bhatt N, Castelino FV, Chung L, Domsic RT, Flaherty KR, Gupta N, Kahaleh B, Martinez FJ, Morrow LE, Moua T, Patel N, Shlobin OA, Southern BD, Volkmann ER, Khanna D. +23 moreeuropepmc +1 more sourceA blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD. [PDF]
Sci Rep, 2023 DiLillo KM, Norman KC, Freeman CM, Christenson SA, Alexis NE, Anderson WH, Barjaktarevic IZ, Barr RG, Comellas AP, Bleecker ER, Boucher RC, Couper DJ, Criner GJ, Doerschuk CM, Wells JM, Han MK, Hoffman EA, Hansel NN, Hastie AT, Kaner RJ, Krishnan JA, Labaki WW, Martinez FJ, Meyers DA, O'Neal WK, Ortega VE, Paine R, Peters SP, Woodruff PG, Cooper CB, Bowler RP, Curtis JL, Arnold KB, SPIROMICS investigators. +33 moreeuropepmc +1 more sourceSystemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. [PDF]
Rheumatology (Oxford), 2023 Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold AM, Distler O, Johannson KA, Allanore Y, Matteson EL, Kawano-Dourado L, Pauling JD, Seibold JR, Volkmann ER, Walsh SLF, Oddis CV, White ES, Barratt SL, Bernstein EJ, Domsic RT, Dellaripa PF, Conway R, Rosas I, Bhatt N, Hsu V, Ingegnoli F, Kahaleh B, Garcha P, Gupta N, Khanna S, Korsten P, Lin C, Mathai SC, Strand V, Doyle TJ, Steen V, Zoz DF, Ovalles-Bonilla J, Rodriguez-Pinto I, Shenoy PD, Lewandoski A, Belloli E, Lescoat A, Nagaraja V, Ye W, Huang S, Maher T, Khanna D. +52 moreeuropepmc +1 more source
